ANGO vs MET · rev $292.5M vs P/E 13, $52.16B cap
AngioDynamics Inc (ANGO) versus MetLife Inc (MET) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
MetLife Inc (MET) is a insurance - life company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
MET does not have a complete income-statement cache yet.
ANGO currently screens at market cap $378.5M. MET currently screens at market cap $52.16B and trailing P/E 12.7.
Not investment advice. Open the ANGO and MET stock pages for the full models.
Not investment advice.